Inhibitors of Dipeptidylpeptidase IV
AssigneeTrustees of Tufts College
InventorsWilliam W. Bachovchin, Hung-sen Lai, Wengen Wu
Life of this patent
Estimating the term…
Abstract
The present invention relates to inhibitors of post-proline cleaving enzymes, such as inhibitors of dipeptidyl peptidase IV, as well as pharmaceutical compositions thereof, and methods for using such inhibitors. In particular, the inhibitors of the present invention are improved over those in the prior art by selection of particular classes of sidechains in the P1 and/or P2 position of the inhibitor that contain a carboxylic acid moiety. The compounds of the present invention can have a better therapeutic index, owing in part to reduced toxicity and/or improved specificity for the targeted protease.
Claims21
1-8. (canceled)
A method of treating Type I diabetes, comprising the step of administering to a mammal in need thereof a therapeutically effective amount of an inhibitor of dipeptidylpeptidase IV (DPIV).
Dependencies are inferred from the claim text.